HA
The startup develops a clinical decision support system that analyzes biosignal data from critically ill patients to diagnose and predict serious diseases. This platform enhances clinical decision-making for healthcare professionals, enabling timely and informed medical interventions.
Updated 3 months ago
Funding
$3.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a clinical decision support system that analyzes biosignal data from critically ill patients to diagnose and predict serious diseases. This platform enhances clinical decision-making for healthcare professionals, enabling timely and informed medical interventions.